“Fresh ideas and multiple disciplines are needed to advance Temporomandibular Disorders (TMDs) research to improve patient care. The National Institutes of Health (NIH) provides approximately one third of all biomedical research funding in the United States and therefore, the interests and priorities of NIH Institutes and Centers can stimulate research interests and training programs throughout the country. TMDs are not the primary mission of any NIH Center or Institute.” (NAM report, Summary S-5)
NIH Grant Funding Opportunities
We invite you to view a list of the latest National Institutes of Health (NIH) funding opportunities for scientists interested in advancing TMJ research.
Table of Opportunities
Notice of Special Interest (NOSI): Maternal Health and the Dental, Oral, and Craniofacial Development of their Children
The National Institute of Dental and Craniofacial Research (NIDCR) is issuing this Notice of Special Interest (NOSI) to encourage research on prenatal environmental and physical stressors experienced by women during pregnancy that affect their child’s dental, oral, and craniofacial (DOC) tissues through altered maternal physiology. The purpose of this NOSI is to support research elucidating the impact of maternal, environmental, nutritional, pharmaceutical, and/or infectious exposures upon the developing and formed oral and craniofacial complex.
More details at: https://grants.nih.gov/grants/guide/notice-files/NOT-DE-23-005.html?utm_medium=email&utm_source=govdelivery
HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
The National Institutes of Health (NIH) intends to support the development of innovative quantitative measures involving myofascial tissues for pain management involving research participants using a two-phase grant funding mechanism. This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to (1) improve treatment for opioid misuse and addiction and (2) enhance pain management. More information about the HEAL Initiative is available at: https://heal.nih.gov/ This notice of a funding opportunity (NOFO) seeks research applications that will develop quantitative measures to facilitate the development of future biomarkers of myofascial tissues and assess their abilities to detect changes in myofascial tissues across a variety of pain management interventions, manipulations, or therapies. Promising quantitative measures may be based on minimally invasive imaging technologies, electrophysiological recordings, integration of multiparametric imaging and electrophysiology approaches, or their integration with other markers (e.g. immune factors, genomic markers, physiological factors) through multiscale modeling or machine learning analysis. The first phase, funded by the R61, will provide funding for up to 3 years to develop quantitative measures that can differentiate abnormal myofascial tissue from healthy tissues, using cross-sectional correlations with clinical signs/symptoms. In addition, the R61 phase should include planning activities for the R33 phase. The second phase, funded under the R33, will support studies to assess the ability of the quantitative measures developed in the R61 phase to detect changes to myofascial tissues across a variety of pain interventions in rigorous, longitudinal clinical studies. The combined R61/R33 cannot exceed 5 years. Transition from the R61 to the R33 phase of the award will be administratively reviewed and will be determined based on successful completion of “Transition Milestones” that need to be clearly specified in the R61 phase application.
More details at: https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-24-003.html?utm_medium=email&utm_source=govdelivery
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 applications on the influence and intersection of sex and gender in health and disease, including: (1) research applications that examine sex and gender factors and their intersection in understanding health and disease; and (2) research that addresses one of the five objectives from Strategic Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women’s Health Research “Advancing Science for the Health of Women.” The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Women’s Health (ORWH) and the scientific partnering Institutes and Centers across NIH.
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-028.html
Understanding Chronic Conditions Understudied Among Women
The purpose of this Notice of Funding Opportunity (NOFO) is to invite R01 & R21 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and underreported in biomedical Research should align with Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women’s Health Research “Advancing Science for the Health of Women.” The awards under this NOFOwill be administered by NIH ICs using funds that have been made available through the Office of Research on Women’s Health (ORWH) and the scientific partnering Institutes and Centers across NIH.
R01: https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-014.html
R21: https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-013.html